Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00804258 · ClinicalTrials.gov registry record
Palliative Care During Intraperitoneal Chemotherapy in Patients With Ovarian Cancer
A clinical trial, sponsored by City of Hope Medical Center.
- Completed
- Registry status
- 17
- Enrollment target
NCT00804258 is a clinical trial that has completed, run by City of Hope Medical Center. The registered enrollment target is 17 participants.
The verdict
NCT00804258 has completed, sponsored by City of Hope Medical Center.
- COMPLETED
- Registry status
- 17 participants
- Enrollment target
Study Summary
RATIONALE: Palliative care may help improve the quality of life of patients with ovarian cancer who are undergoing intraperitoneal chemotherapy. PURPOSE: This clinical trial is studying palliative care in patients with ovarian cancer who are undergoing intraperitoneal chemotherapy.
Interventions
- OTHER medical chart review
- OTHER questionnaire administration
- OTHER educational intervention
- PROCEDURE assessment of therapy complications
- DRUG intraperitoneal chemotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2007-08 |
| Est. Completion | 2012-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00804258
The ClinicalTrials.gov registry entry for NCT00804258 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is City of Hope Medical Center, which has 582 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which medical chart review is the first listed.
NCT00804258 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00804258 about?
NCT00804258 is a clinical study titled "Palliative Care During Intraperitoneal Chemotherapy in Patients With Ovarian Cancer". RATIONALE: Palliative care may help improve the quality of life of patients with ovarian cancer who are undergoing intraperitoneal chemotherapy. PURPOSE: This clinical trial is studying palliative care in patients with ovarian cancer who are undergoing intraperitoneal chemotherapy.
What is the current status of trial NCT00804258?
This trial is currently completed. The enrollment target is 17 participants. The study started on 2007-08. Estimated completion is 2012-01.
What interventions are being tested in trial NCT00804258?
The interventions under investigation include: medical chart review (OTHER), questionnaire administration (OTHER), educational intervention (OTHER), assessment of therapy complications (PROCEDURE), intraperitoneal chemotherapy (DRUG).
Who is sponsoring clinical trial NCT00804258?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.